{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T06:42:50Z","timestamp":1695105770720},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,3]]},"abstract":"<jats:p>Refractory\/relapsed Langerhans cell histiocytosis (LCH) has a difficult course with a guarded prognosis. Salvage treatments available are both expensive and highly toxic. On the basis of the pathophysiology of LCH, we used a novel protocol including pulse dexamethasone and lenalidomide in a child with refractory LCH involving the choroid plexus, which resulted in durable remission with minimal toxicity. The protocol was extrapolated from the FIRST trial for patients with multiple myeloma. We present the clinical course, treatment protocol, and outcome in this child, who is at present disease free and in remission 18 months posttreatment.<\/jats:p>","DOI":"10.1097\/mph.0000000000000735","type":"journal-article","created":{"date-parts":[[2017,1,18]],"date-time":"2017-01-18T05:07:40Z","timestamp":1484716060000},"page":"e74-e78","source":"Crossref","is-referenced-by-count":2,"title":["Successful Treatment of Refractory Langerhans Cell Histiocytosis of the Choroid Plexus in a Child With Pulse Dexamethasone and Lenalidomide"],"prefix":"10.1097","volume":"39","author":[{"given":"Ramya","family":"Uppuluri","sequence":"first","affiliation":[{"name":"Pediatric Hematology, Oncology and BMT"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sreejith","family":"Ramachandrakurup","sequence":"additional","affiliation":[{"name":"Pediatric Hematology, Oncology and BMT"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravikanth","family":"Balaji","sequence":"additional","affiliation":[{"name":"Radiology, Apollo Specialty Hospital, Chennai, Tamil Nadu, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Divya","family":"Subburaj","sequence":"additional","affiliation":[{"name":"Pediatric Hematology, Oncology and BMT"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atish","family":"Bakane","sequence":"additional","affiliation":[{"name":"Pediatric Hematology, Oncology and BMT"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Revathi","family":"Raj","sequence":"additional","affiliation":[{"name":"Pediatric Hematology, Oncology and BMT"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230918","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1136\/adc.2008.144527","article-title":"Incidence and clinical features of Langerhans cell histiocytosis in the UK and Ireland","volume":"94","author":"Salotti","year":"2009","journal-title":"Arch Dis Child"},{"key":"R2-20230918","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/pbc.21504","article-title":"Incidence of Langerhans cell histiocytosis in children: a population-based study","volume":"51","author":"St\u00e5lemark","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"R3-20230918","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.3171\/jns.1995.83.6.1080","article-title":"Huge Langerhans cell histiocytosis granuloma of choroid plexus in a child with Hand-Schuller-Christian disease. Case report","volume":"83","author":"Kim","year":"1995","journal-title":"J Neurosurg"},{"key":"R4-20230918","first-page":"880","article-title":"MR imaging presentation of intracranial disease associated with Langerhans cell histiocytosis","volume":"25","author":"Prayer","year":"2004","journal-title":"AJNR Am J Neuroradiol"},{"key":"R5-20230918","doi-asserted-by":"crossref","first-page":"873.e1","DOI":"10.1016\/j.jpeds.2010.03.001","article-title":"Central nervous system disease in Langerhans cell histiocytosis","volume":"156","author":"Grois","year":"2010","journal-title":"J Pediatr"},{"key":"R6-20230918","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1750-1172-6-83","article-title":"Efficacy of vinblastine in central nervous system Langerhans cell histiocytosis: a nationwide retrospective study","volume":"6","author":"Ng Wing Tin","year":"2011","journal-title":"Orphanet J Rare Dis"},{"key":"R7-20230918","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1182\/blood-2015-03-635151","article-title":"Cladribine and cytarabine in refractory multisystem Langerhans cell histiocytosis: results of an international phase 2 study","volume":"126","author":"Donadieu","year":"2015","journal-title":"Blood"},{"key":"R8-20230918","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/sj.bmt.1705015","article-title":"Improved outcome of treatment-resistant high-risk Langerhans cell histiocytosis after allogeneic stem cell transplantation with reduced-intensity conditioning","volume":"36","author":"Steiner","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"R9-20230918","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1001\/jamaoncol.2015.0736","article-title":"Vemurafenib use in an infant for high-risk Langerhans cell histiocytosis","volume":"1","author":"H\u00e9ritier","year":"2015","journal-title":"JAMA Oncol"},{"key":"R10-20230918","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1182\/blood-2012-07-446286","article-title":"Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation","volume":"121","author":"Haroche","year":"2013","journal-title":"Blood"},{"key":"R11-20230918","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/pbc.20578","article-title":"A phase II trial using thalidomide for Langerhans cell histiocytosis","volume":"48","author":"McClain","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"R12-20230918","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1365-2230.1993.tb02262.x","article-title":"Remission of Langerhans cell histiocytosis with thalidomide treatment","volume":"18","author":"Misery","year":"1993","journal-title":"Clin Exp Dermatol"},{"key":"R13-20230918","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1182\/blood-2014-02-556407","article-title":"Blood spotlight on Langerhans cell histiocytosis","volume":"124","author":"Delprat","year":"2014","journal-title":"Blood"},{"key":"R14-20230918","doi-asserted-by":"crossref","first-page":"e16555","DOI":"10.1200\/jco.2013.31.15_suppl.e16555","article-title":"Treatment of recurrent Langerhans cell histiocytosis of the vulva with lenalidomide","volume":"31","author":"Ibrahim","year":"2013","journal-title":"J Clin Oncol"},{"key":"R15-20230918","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3109\/0284186X.2011.631581","article-title":"Lenalidomide proved effective in multisystem Langerhans cell histiocytosis","volume":"51","author":"Szturz","year":"2012","journal-title":"Acta Oncol"},{"key":"R16-20230918","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1182\/blood.V122.21.2.2","article-title":"Initial phase 3 results of the First (frontline investigation of lenalidomide+dexamethasone versus standard thalidomide) trial (MM-020\/IFM 07 01) in newly diagnosed multiple myeloma (NDMM) patients (pts) ineligible for stem cell transplantation (SCT)","volume":"122","author":"Facon","year":"2013","journal-title":"Blood"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00043426-201703000-00026","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T05:51:59Z","timestamp":1695016319000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-201703000-00026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000000735","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]}}}